News | Breast Density | October 21, 2019

Partnership will provide access to artificial intelligence-powered breast density assessment to Nuance’s nationwide network of radiologists

Densitas Breast Density Assessment Software Joins Nuance AI Marketplace

October 21, 2019 — Densitas Inc. announced that its U.S. Food and Drug Administration (FDA)-cleared densitas densityai breast density assessment software will be available on the Nuance AI Marketplace. The company said the marketplace provides access to more than 70 percent of all radiologists across the largest network of connected healthcare facilities in the U.S.

Densitas densityai delivers fully automated, standardized and reproducible breast density assessments from standard DICOM (Digital Imaging and Communications in Medicine) clinical use images. Density assessments can be incorporated into risk models that evaluate patient-specific breast cancer risk. The artificial intelligence (AI)-powered densitas densityai solution is specifically designed to align with how the visual cortex processes breast images when radiologists visualize mammograms, and rapidly generates reproducible and standardized breast density assessments that line up with the American College of Radiology (ACR) Breast Imaging-Reporting and Data System) BI-RADS 5th ed. Atlas guidance on interpreting breast density from clinical use mammograms. Densitas recently announced that densitas densityai has been selected for use in a major breast screening trial in Germany.

"AI can play an important supporting role for radiologists by automating routine, time-consuming, subjective and fatiguing tasks so that they can focus on more challenging interpretive tasks," said Woojin Kim, M.D., chief medical information officer at the Healthcare Division of Nuance Communications. "What sets densitas densityai apart is that it has been thoughtfully designed to process routinely archived mammograms so that breast density assessments can be obtained from historical studies when comparing current with prior exams.  What I find compelling is that the density results are deeply embedded in the reporting workflow to deliver important information to radiologists at the time of interpretation while automatically populating the report."

Watch the VIDEO: The Role of Analytics in Value-Based Healthcare, an interview with Kim

Listen to the PODCAST: Why Blockchain Matters In Medical Imaging, an interview with Kim

For more information: www.densitas.health, www.nuance.com


Related Content

News | Radiology Imaging

Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...

Time February 13, 2026
arrow
Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
Subscribe Now